ABO血型不合红细胞浓缩液输注引起急性溶血反应的血浆交换:单中心经验。

IF 1.5 4区 医学 Q3 HEMATOLOGY Transfusion Medicine Pub Date : 2023-10-01 Epub Date: 2023-06-28 DOI:10.1111/tme.12982
Neslihan Andıç, Hava Üsküdar Teke, Eren Gündüz
{"title":"ABO血型不合红细胞浓缩液输注引起急性溶血反应的血浆交换:单中心经验。","authors":"Neslihan Andıç,&nbsp;Hava Üsküdar Teke,&nbsp;Eren Gündüz","doi":"10.1111/tme.12982","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Acute hemolytic transfusion reaction (AHTR) due to ABO-incompatible erythrocyte concentrate (EC) is one of the most catastrophic complications of transfusion. Since the hemolysis is intravascular; hemoglobinemia and hemoglobinuria result in disseminated intravascular coagulation (DIC), acute renal failure, shock, and sometimes death.</p><p><strong>Background: </strong>Treatment of AHTR is mostly supportive measures. Today there are no clear suggestions about plasma exchange (PE) in these patients.</p><p><strong>Methods/materials: </strong>Here we report our experience with six patients diagnosed with AHTR due to ABO-incompatible EC transfusion.</p><p><strong>Results: </strong>We performed PE in 5 of these patients. Although all of our patients were geriatric and most of them had significant comorbidities four out of five patients recovered without an incident.</p><p><strong>Conclusion: </strong>Although PE is considered a last-chance treatment when other measures fail in the literature, our experience above indicates that it must be evaluated in every patient with AHTR early in the course. If the patient has cardiac and renal comorbidities, large volume EC is transfused, DAT is negative, plasma color is red and there is macroscopic hemoglobinuria, we suggest performing PE.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":"409-412"},"PeriodicalIF":1.5000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Plasma exchange in acute hemolytic reaction due to ABO-incompatible erythrocyte concentrate transfusions: Single center experience.\",\"authors\":\"Neslihan Andıç,&nbsp;Hava Üsküdar Teke,&nbsp;Eren Gündüz\",\"doi\":\"10.1111/tme.12982\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Acute hemolytic transfusion reaction (AHTR) due to ABO-incompatible erythrocyte concentrate (EC) is one of the most catastrophic complications of transfusion. Since the hemolysis is intravascular; hemoglobinemia and hemoglobinuria result in disseminated intravascular coagulation (DIC), acute renal failure, shock, and sometimes death.</p><p><strong>Background: </strong>Treatment of AHTR is mostly supportive measures. Today there are no clear suggestions about plasma exchange (PE) in these patients.</p><p><strong>Methods/materials: </strong>Here we report our experience with six patients diagnosed with AHTR due to ABO-incompatible EC transfusion.</p><p><strong>Results: </strong>We performed PE in 5 of these patients. Although all of our patients were geriatric and most of them had significant comorbidities four out of five patients recovered without an incident.</p><p><strong>Conclusion: </strong>Although PE is considered a last-chance treatment when other measures fail in the literature, our experience above indicates that it must be evaluated in every patient with AHTR early in the course. If the patient has cardiac and renal comorbidities, large volume EC is transfused, DAT is negative, plasma color is red and there is macroscopic hemoglobinuria, we suggest performing PE.</p>\",\"PeriodicalId\":23306,\"journal\":{\"name\":\"Transfusion Medicine\",\"volume\":\" \",\"pages\":\"409-412\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transfusion Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/tme.12982\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/6/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/tme.12982","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:ABO血型不合的红细胞浓缩物(EC)引起的急性溶血性输血反应(AHTR)是最严重的输血并发症之一。由于溶血是血管内的;血红蛋白血症和血红蛋白尿可导致弥散性血管内凝血(DIC)、急性肾功能衰竭、休克,有时甚至死亡。背景:AHTR的治疗主要是支持性措施。目前还没有关于这些患者血浆置换(PE)的明确建议。方法/材料:我们报告了6例因ABO血型不合EC输血而被诊断为AHTR的患者的经验。结果:我们对其中5例患者进行了PE。尽管我们所有的患者都是老年人,而且大多数患者都有严重的合并症,但五分之四的患者康复后没有发生任何意外。结论:尽管在文献中,当其他措施失败时,PE被认为是最后的机会治疗,但我们以上的经验表明,必须在每个AHTR患者的病程早期对其进行评估。如果患者有心脏和肾脏合并症,大量输注EC,DAT为阴性,血浆颜色为红色,并有肉眼可见的血红蛋白尿,我们建议进行PE。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Plasma exchange in acute hemolytic reaction due to ABO-incompatible erythrocyte concentrate transfusions: Single center experience.

Objectives: Acute hemolytic transfusion reaction (AHTR) due to ABO-incompatible erythrocyte concentrate (EC) is one of the most catastrophic complications of transfusion. Since the hemolysis is intravascular; hemoglobinemia and hemoglobinuria result in disseminated intravascular coagulation (DIC), acute renal failure, shock, and sometimes death.

Background: Treatment of AHTR is mostly supportive measures. Today there are no clear suggestions about plasma exchange (PE) in these patients.

Methods/materials: Here we report our experience with six patients diagnosed with AHTR due to ABO-incompatible EC transfusion.

Results: We performed PE in 5 of these patients. Although all of our patients were geriatric and most of them had significant comorbidities four out of five patients recovered without an incident.

Conclusion: Although PE is considered a last-chance treatment when other measures fail in the literature, our experience above indicates that it must be evaluated in every patient with AHTR early in the course. If the patient has cardiac and renal comorbidities, large volume EC is transfused, DAT is negative, plasma color is red and there is macroscopic hemoglobinuria, we suggest performing PE.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Transfusion Medicine
Transfusion Medicine 医学-血液学
CiteScore
2.70
自引率
0.00%
发文量
96
审稿时长
6-12 weeks
期刊介绍: Transfusion Medicine publishes articles on transfusion medicine in its widest context, including blood transfusion practice (blood procurement, pharmaceutical, clinical, scientific, computing and documentary aspects), immunohaematology, immunogenetics, histocompatibility, medico-legal applications, and related molecular biology and biotechnology. In addition to original articles, which may include brief communications and case reports, the journal contains a regular educational section (based on invited reviews and state-of-the-art reports), technical section (including quality assurance and current practice guidelines), leading articles, letters to the editor, occasional historical articles and signed book reviews. Some lectures from Society meetings that are likely to be of general interest to readers of the Journal may be published at the discretion of the Editor and subject to the availability of space in the Journal.
期刊最新文献
Factors influencing white blood cell mobilisation in healthy granulocyte donors. Validation of current commercially-available devices to thaw pooled, solvent/detergent-treated human plasma. Acute normovolemic haemodilution to reduce allogeneic red blood cell transfusion in patients undergoing coronary artery bypass grafting. An observational study. An unusual case of reagent interference in transfusion medicine workup: Pan reactive indirect antiglobulin test caused by commercial saline solution. PacBio third-generation sequencing detects a new variant, c.27delC, in exon 1 of the ABO gene resulting in a weak B phenotype.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1